RT @NCICancerBio: In an @theNCI funded study, @ZeevRonai et al. @SBPdiscovery found that IMD-0354 (a small molecule) is a potent inhibitor…
RT @NCICancerBio: In an @theNCI funded study, @ZeevRonai et al. @SBPdiscovery found that IMD-0354 (a small molecule) is a potent inhibitor…
RT @NCICancerBio: In an @theNCI funded study, @ZeevRonai et al. @SBPdiscovery found that IMD-0354 (a small molecule) is a potent inhibitor…
RT @NCICancerBio: In an @theNCI funded study, @ZeevRonai et al. @SBPdiscovery found that IMD-0354 (a small molecule) is a potent inhibitor…
RT @NCICancerBio: In an @theNCI funded study, @ZeevRonai et al. @SBPdiscovery found that IMD-0354 (a small molecule) is a potent inhibitor…
In an @theNCI funded study, @ZeevRonai et al. @SBPdiscovery found that IMD-0354 (a small molecule) is a potent inhibitor of #glutamine uptake and suppresses #melanoma growth in experimental models @MCT_AACR https://t.co/rDjrm5AJTc. https://t.co/DNzAF6EPWH
Starving tumors by blocking glutamine uptake https://t.co/aJPYXI3kgF https://t.co/QHMwUNwPz3 https://t.co/jrxchzyOlJ
#Identification and #Characterization of #IMD0354 as a Glutamine Carrier Protein Inhibitor in #Melanoma https://t.co/Udwf56WggY | via @MCT_AACR
Read the study here: https://t.co/mDXuYAm7S4
Study by scientists at @SBPdiscovery | Identification and characterization of IMD-0354 as a glutamine carrier protein Inhibitor in #melanoma. 🔬 Abstract in @MCT_AACR: https://t.co/9gxcLWyeKV https://t.co/RQs5ZsWVpL
Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in Melanoma. https://t.co/BnF2z7acA7 https://t.co/YRtBBgUGZF
New article: Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in Melanoma https://t.co/mFiFsyPTTL #melanoma #oncology https://t.co/Gvmy1tC687